CD24 and breast carcinoma: It has been reported that CD24 is highly expressed and interacts with the inhibitory receptor sialic acid‐binding Ig‐like lectin 10 (Siglec‐10), which is expressed by tumor‐associated macrophages to promote immune evasion in ovarian cancer and breast cancer (Barkal et al., 2019).